Advertisement

Kinins as Neuropeptides

  • David C. Perry
Part of the GWUMC Department of Biochemistry Annual Spring Symposia book series (GWUN)

Abstract

The kinins, including the nonapeptide bradykinin (BK) as well as several other peptide analogues of BK, have been known since their initial discovery (Rocha e Silva, 1949) to be highly active in a number of peripheral organ systems. The recent explosion of research on brain peptides has renewed interest in the possibility that kinins may also play roles as neuropeptides. In this chapter I review evidence that BK and other kinins may be acting as neuroactive peptides, especially in the central nervous system.

Keywords

Pressor Response Mean Arterial Blood Pressure Tissue Kallikrein Sedation Phase Unanesthetized Rabbit 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Almeida de Silva, T. C., and Pela, I. R., 1978, Changes in rectal temperature of the rabbit by intracerebroventricular injection of bradykinin and related peptides, Agents Actions 8:102–107.CrossRefGoogle Scholar
  2. Armstrong, D., 1970, Pain, in: Bradykinin, Kallidin and Kallikrein. Handbook of Experimental Pharmacology, Vol. 25 (E. G. Erdos, ed.), Springer-Verlag, Berlin, pp. 434–481.Google Scholar
  3. Baccaglini, P. I., and Hogan, P. G., 1983, Some rat sensory neurons in culture express characteristics of differentiated pain sensory cells, Proc. Natl. Acad. Sci. U.S.A. 80:594–598.PubMedCrossRefGoogle Scholar
  4. Barasi, S., and Wright, D. M., 1979, Effects of bradykinin on central neurons, in: Advances in Pain Research and Therapy, Vol. 3 (J. J. Bonica, ed.), Raven Press, New York, pp. 883–888.Google Scholar
  5. Bareis, D. L., Manganiello, V. C., Hirata, F., Vaughan, M., and Axelrod, J., 1983, Bradykinin stimulates phospholipid methylation, calcium influx, prostaglandin formation, and cAMP accumulation in human fibroblasts, Proc. Natl. Acad. Sci. U.S.A. 80:2514–2518.PubMedCrossRefGoogle Scholar
  6. Belcher, G., 1979, The effects of intra-arterial bradykinin, histamine, acetylcholine and prostaglandin E1 on nociceptive and non-nociceptive dorsal horn neurones of the cat, Eur. J. Pharmacol. 56:385–395.PubMedCrossRefGoogle Scholar
  7. Braas, K. M., Manning, D. C., Wilson, V. S., Perry, D. C., Stewart, J. M., Vavreck, R. J., and Snyder, S. H., 1985, Characterization of bradykinin antagonists in a cultured neuronal cell line, Neuroscience Abstr. 11:414.Google Scholar
  8. Buccafusco, J. J., and Serra, M., 1985, Role of cholinergic neurons in the cardiovascular responses evoked by central injection of bradykinin or angiotensin II in conscious rats, Eur. J. Pharmacol. 113:43–51.PubMedCrossRefGoogle Scholar
  9. Bynke, G., Hakanson, R., Hörig, J., and Leander, S., 1983, Bradykinin contracts the pupillary sphincter and evokes ocular inflammation through release of neuronal substance P, Eur. J. Pharmacol. 91:469–475.PubMedCrossRefGoogle Scholar
  10. Camargo, A. C. M., Ramalho-Pinto, F. J., and Greene, L. J., 1972, Brain peptidases: Conversion and inactivation of kinin hormones, J. Neurochem. 19:37–49.PubMedCrossRefGoogle Scholar
  11. Capek, R., Masek, K., Sramka, M., Krsiak, M., and Svec, P., 1969, The similarities of the angiotensin and bradykinin action on the central nervous system, Pharmacology 2:161–170.PubMedCrossRefGoogle Scholar
  12. Carretero, O. A., and Scicli, A. G., 1980, The renal kallikrein-kinin system, Am. J. Physiol. 238:F247–F255.PubMedGoogle Scholar
  13. Chahl, L. A., and Iggo, A., 1977, The effects of bradykinin and prostaglandin Ei on rat cutaneous afferent nerve activity, Br. J. Pharmacol. 59:343–347.PubMedGoogle Scholar
  14. Chao, J., Woodley, C., Chao, L., and Margolius, H. S., 1983, Identification of tissue kallikrein in rat brain and in the cell-free translation product encoded by rat brain mRNA, J. Biol. Chem. 258:15173–15178.PubMedGoogle Scholar
  15. Chao, J., Chao, L., Ando, T., and Margolius, H., 1985, Kallikrein, kallikrein binding protein and kininogen in rat brain and in neuroblastoma x glioma hybrid cells, Clin. Res. 33:532A.Google Scholar
  16. Chapman, L. F., Ramos, A. O., Goodell, H., and Wolff, H. G., 1961, Neurohumoral features of afferent fibers in man, Arch. Neurol. 4:49–82.CrossRefGoogle Scholar
  17. Clark, W. G., 1979, Kinins and the peripheral and central nervous system, in: Bradykinin, Kallidin and Kallikrein, Handbook of Experimental Pharmacology, Vol. 25, Suppl. (E. G. Erdos, ed.), Springer-Verlag, Berlin, pp. 311–356.Google Scholar
  18. Clyman, R. I., Blacksin, A. S., Manganiello, V. C., and Vaughan, M., 1975, Oxygen and cyclic nucleotides in the human umbilical artery, Proc. Natl. Acad. Sci. U.S.A. 72:3883–3887.PubMedCrossRefGoogle Scholar
  19. Correa, F. M. A., and Graeff, F. G., 1974, Central mechanisms of the hypertensive action of intra-ventricular bradykinin in the unanesthetized rat, Neuropharmacology 13:65–75.PubMedCrossRefGoogle Scholar
  20. Correa, F. M. A., and Graeff, F. G., 1975, Central site of the hypertensive action of bradykinin, J. Pharmacol. Exp. Ther. 192:670–676.PubMedGoogle Scholar
  21. Correa, F. M. A., and Graeff, F. G., 1976, On the mechanisms of the hypertensive action of intraseptal bradykinin in the rat, Neuropharmacology 15:713–717.PubMedCrossRefGoogle Scholar
  22. Correa, F. M. A., Innis, R. B., Uhl, G. R., and Snyder, S. H., 1979, Bradykinin-like immunoreactive neuronal systems localized histochemically in rat brain, Proc. Natl. Acad. Sci. U.SA. 76:1489–1493.CrossRefGoogle Scholar
  23. Damas, J., 1972, La demi-vie de la bradykinine dans les espaces sous-arachnoides du rat, C.R. Soc. Biol. (Paris), 166:740–744.Google Scholar
  24. DaSilva, G. R., and Rocha e Silva, M., 1971, Catatonia induced in the rabbit by intracerebral injection of bradykinin and morphine, Eur. J. Pharmacol. 15:180–186.CrossRefGoogle Scholar
  25. Diz, D. I., and Jacobowitz, D. M., 1984, Cardiovascular effects of discrete intrahypothalamic and preoptic injections of bradykinin, Brain Res. Bull. 12:409–417.PubMedCrossRefGoogle Scholar
  26. Douglas, W. W., 1980, Polypeptides—angiotensin, plasmakinins, and others, in: The Pharmacological Basis of Therapeutics, 6th ed. (A. Goodman Gilman, L. S. Goodman, and A. Gilman, eds.), Macmillan, New York, pp. 647–667.Google Scholar
  27. Erdos, E. G. (ed.), 1970, Bradykinin, Kallidin and Kallikrein. Handbook of Experimental Pharmacology, Vol. 25, Springer-Verlag, Berlin, Heidelberg, New York.Google Scholar
  28. Ferreira, S. H., 1972, Prostaglandins, aspirin-like drugs and analgesia, Nature 240:200–203.CrossRefGoogle Scholar
  29. Frederick, M. J., Vavreck, R. J., Stewart, J. M., and Odya, C. E., 1984, Further studies of myometrial bradykinin receptor-like binding, Biochem. Pharmacol. 18:2887–2892.CrossRefGoogle Scholar
  30. Frucht, H., Lilling, G., and Beitner, R., 1984, Influence of bradykinin on glucose 1,6-bisphosphate and cyclic GMP levels and on the activities of glucose 1,6-bisphosphatase, phosphofructokinase and phosphoglucomutase in muscle, Int. J. Biochem. 16:397–402.PubMedCrossRefGoogle Scholar
  31. Goldstein, D. J., Ropchak, T. G., Keiser, H. R., Atta, G. J., Argiolas, A., and Pisano, J. J., 1983, Bradykinin reverses the effect of opiates in the gut by enhancing acetylcholine release, J. Biol. Chem. 258:12122–12124.PubMedGoogle Scholar
  32. Graeff, F. G., and Arisawa, E. A. L., 1978, Effect of intracerebroventricular bradykinin, angiotensin II and substance P on multiple fixed-interval fixed-ratio responding in rabbits, Psychopharmacology 57:89–95.PubMedCrossRefGoogle Scholar
  33. Graeff, F. G., Pela, I. R., and Rocha e Silva, M., 1969, Behavioral and somatic effects of bradykinin injected into the cerebral ventricles of unanesthetized rabbits, Br. J. Pharmacol. 37:723–732.PubMedGoogle Scholar
  34. Hoffman, W. E., and Schmid, P. G., 1978, Separation of pressor and anti-diuretic effects of intraven-tricular bradykinin, Neuropharmacology 17:992–1002.Google Scholar
  35. Hori, S., 1968, The presence of bradykinin-like polypeptides, kinin-releasing and destroying activity in the brain, Jpn. J. Pharmacol. 18:772–787.Google Scholar
  36. Innis, R. B., Manning, D. C., Stewart, J. M., and Snyder, S. H., 1981, [3H]Bradykinin receptor binding in mammalian tissue membranes, Proc. Natl. Acad. Sci. U.S.A. 78:2630–2634.PubMedCrossRefGoogle Scholar
  37. Inoki, R., Hayashi, T., Kudo, T., and Matsumoto, K., 1978, Effects of aspirin and morphine on the release of a bradykinin-like substance into the subcutaneous perfusate of the rat paw, Pain 5:53–68.PubMedCrossRefGoogle Scholar
  38. Inouye, A., Kataoka, K., and Tsujioka, T., 1961, On a kinin-like substance in the nervous tissue extracts treated with trypsin, Jpn. J. Physiol. 11:319–334.PubMedCrossRefGoogle Scholar
  39. Iwata, H., Shikimi, T., and Oka, T., 1969, Pharmacological significance of peptidase and proteinase in the brain: Enzymatic inactivation of bradykinin in the rat brain, Biochem. Pharmacol. 18:119–128.PubMedCrossRefGoogle Scholar
  40. Iwata, H., Shikimi, T., Iida, ML, and Miichi, H., 1970, Effect of bradykinin on the central nervous system and role of the enzyme inactivating bradykinin in the mouse brain, Jpn. J. Pharmacol. 20:80–86.PubMedCrossRefGoogle Scholar
  41. Iwata, T., Hashimoto, H., Hiwada, K., and Kokubu, T., 1984, Changes of plasma renin activity by intracerebroventricular administration of biologically active peptides in conscious rats, Clin. Exp. Hypertension A6:1055–1066.CrossRefGoogle Scholar
  42. Johnson, A. R., 1979, Effects of kinins in organ systems, in: Bradykinin, Kallidin and Kallikrein. Handbook of Experimental Pharmacology, Vol. 25, Suppl. (E. G. Erdos, ed.), Springer-Verlag, Berlin, pp. 357–399.Google Scholar
  43. Juan, H., and Lembeck, F., 1974, Actions of peptides and other algesic agents on paravascular pain receptors of the isolated perfused rabbit ear, Naunyn Schmiedebergs Arch. Pharmacol. 290:389–395.CrossRefGoogle Scholar
  44. Kariya, K., and Yamauchi, A., 1981, Effects of intraventricular injection of bradykinin on the EEG and the blood pressure in conscious rats, Neuropharmacology 20:1221–1224.PubMedCrossRefGoogle Scholar
  45. Kariya, K., Iwaki, H., Ihda, M., Maruta, E., and Murasa, M., 1981, Electroencephalogram of bradykinin and its degradation system in rat brain, Jpn. J. Pharmacol. 31:261–267.PubMedCrossRefGoogle Scholar
  46. Kariya, K., Yamauchi, A., and Chatani, Y., 1982a, Relationship between central actions of bradykinin and prostaglandins in the conscious rat, Neuropharmacology 21:267–272.PubMedCrossRefGoogle Scholar
  47. Kariya, K., Yamauchi, A., Hattori, S., Tsuda, Y., and Okata, Y., 1982b, The disappearance rate of intraventricular bradykinin in the brain of the conscious rat, Biochem. Biophys. Res. Commun. 107:1461–1466.PubMedCrossRefGoogle Scholar
  48. Kaufman, M. P., Coleridge, H. M., Coleridge, J. C. G., and Baker, D. G., 1980a, Bradykinin stimulates afferent vagal C-fibers in intrapulmonary airways of dogs, J. Appl. Physiol. 48:511–517.PubMedGoogle Scholar
  49. Kaufman, M. P., Baker, D. G., Coleridge, H. M., and Coleridge, J. C. G., 1980b, Stimulation by bradykinin of afferent vagal C-fibers with chemosensitive endings in the heart and aorta of the dog, Circ. Res. 46:476–484.PubMedGoogle Scholar
  50. Kellermeyer, R. W., and Graham, R. C., 1968, Kinins—possible physiologic and pathologic roles in man, N. Engl. J. Med. 279:754–759, 802-807; 859-866.PubMedCrossRefGoogle Scholar
  51. Kondo, K., Okuno, T., Konishi, K., Saruta, T., and Kato, E., 1979, Central and peripheral effects of bradykinin and prostaglandin E2 in blood pressure in conscious rats, Naunyn Schmiedebergs Arch. Pharmacol. 308:111–115.PubMedCrossRefGoogle Scholar
  52. Lambert, G. A., and Lang, W. J., 1970, The effects of bradykinin and eledoisin injected into the cerebral ventricles of conscious rats, Eur. J. Pharmacol. 9:383–386.PubMedCrossRefGoogle Scholar
  53. Lembeck, F., Popper, H., and Juan, H., 1976, Release of prostaglandins by bradykinin as an instrinsic mechanism of its algesic effect. Naunyn Schmiedebergs Arch. Pharmacol. 294:69–73.PubMedCrossRefGoogle Scholar
  54. Lewis, G. P., and Reit, E., 1965, The action of angiotensin and bradykinin on the superior cervical ganglion of the cat, J. Physiol. (Lond.) 179:538–553.Google Scholar
  55. Lewis, R. E., and Phillips, M. I., 1984, Localization of the central pressor action of bradykinin to the cerebral third ventricle, Am. J. Physiol. 247:R63-R68.Google Scholar
  56. Lewis, R. E., Hoffman, W. E., and Phillips, M. I., 1983, Angiotensin II and bradykinin: Interactions between two centrally active peptides, Am. J. Physiol. 244:R285–R291.PubMedGoogle Scholar
  57. Lim, R. K. S., 1970, Pain, Annu. Rev. Physiol 32:269–288.CrossRefGoogle Scholar
  58. Manning, D. C., and Snyder, S. H., 1983, [3H]Bradykinin receptor localization in spinal cord and sensory ganglia—evidence for a role in primary afferent function, Neurosci. Abstr. 9:590.Google Scholar
  59. Manning, D. C., and Snyder, S. H., 1986, [3H]Bradykinin binding site localization in guinea pig urinary system, in: Kinins IV(A) (L. M. Greenbaum and H. S. Margolius, eds.), Plenum Press, New York, pp. 561–568.Google Scholar
  60. Manning, D. C., Snyder, S. H., Kachur, J. F., Miller, R. J., and Field, M., 1982, Bradykinin receptor-mediated chloride secretion in intestinal function, Nature 299:256–259.PubMedCrossRefGoogle Scholar
  61. McGiff, J. C., Itskovitz, H. D., Terragno, N. A., and Wong, P. Y. K., 1976, Modulation and mediation of the action of the renal kallikrein-kinin system by prostaglandins, Fed. Proc. 35:175–180.PubMedGoogle Scholar
  62. Melo, J. C., and Graeff, F. G., 1975, Effect of intracerebroventricular bradykinin and related peptides on rabbit opérant behavior, J. Pharmacol. Exp. Ther. 193:1–10.PubMedGoogle Scholar
  63. Moniuszko-Jakoniuk, J., Wisniewski, K., and Koscielak, M., 1976, Investigations of the mechanism of central action of kinins, Psychopharmacology 50:181–186.PubMedCrossRefGoogle Scholar
  64. Nawa, H., Kitamura, N., Hirose, T., Asai, M., Inayama, S., and Nakanishi, S., 1983, Primary structures of bovine liver low molecular weight kininogen precursors and their two mRNAs, Proc. Natl. Acad. Sci. U.S.A. 80:90–94.PubMedCrossRefGoogle Scholar
  65. Odya, C. E., Goodfriend, T. L., and Pena, C., 1980, Bradykinin receptor-like binding studied with iodinated analogues, Biochem. Pharmacol. 29:175–185.PubMedCrossRefGoogle Scholar
  66. Okada, Y., Tuchiya, Y., Yagyu, M., Kozawa, S., and Kariya, K., 1977, Synthesis of bradykinin fragments and their effects on pentobarbital sleeping time in mouse, Neuropharmacology 16:381–383.PubMedCrossRefGoogle Scholar
  67. Oliveira, E. B., Martino, A. R., and Camargo, A. C. M., 1976, Isolation of brain endopeptidases: Influence of size and sequences of substrates structurally related to bradykinin, Biochemistry 15:1967–1974.PubMedCrossRefGoogle Scholar
  68. Pearson, L., Lambert, G. A., and Lang, W. J., 1969, Centrally mediated cardiovascular and EEG responses to bradykinin and eledoisin, Eur. J. Pharmacol. 8:153–158.PubMedCrossRefGoogle Scholar
  69. Pela, I. R., Gardey-Levassort, C., Lechat, P., and Rocha e Silva, M., 1975, Brain kinins and fever induced by bacterial pyrogens in rabbits, J. Pharm. Pharmacol. 27:793–794.PubMedCrossRefGoogle Scholar
  70. Perry, D. C., and Snyder, S. H., 1984, Identification of authentic bradykinin in mammalian brain, J. Neurochem. 43:1072–1080.PubMedCrossRefGoogle Scholar
  71. Phillips, M. I., Summers, C., Lewis, R., Hoffman, L., and Casto, R., 1982, Cardiovascular effects of neuropeptides in brain and periphery, Fed. Proc. 41:1661.Google Scholar
  72. Phillis, J. W., and Limacher, J. J., 1974, Excitation of cerebral cortical neurons by various polypeptides, Exp. Neurol. 43:414–423.PubMedCrossRefGoogle Scholar
  73. Pisano, J. J., and Austen, K. F. (eds.), 1974, Chemistry and Biology of the Kallikrein-Kinin System in Health and Disease, DHEW Publication No. NIH76-791, U.S. Government Printing Office, Washington.Google Scholar
  74. Regoli, D., and Barabe, J., 1980, Pharmacology of bradykinin and related kinins, Pharmacol. Rev. 32:1–46.PubMedGoogle Scholar
  75. Reiser, G., and Hamprecht, B., 1982, Bradykinin induces hyperpolarizations in rat glioma cells and in neuroblastoma × glioma hybrid cells, Brain Res. 239:191–199.PubMedCrossRefGoogle Scholar
  76. Reiser, G., Walter, U., and Hamprecht, B., 1984, Bradykinin regulates the level of guanosine 3′,5′-cyclic monophosphate (cyclic GMP) in neural cell lines, Brain Res. 290:367–371.PubMedCrossRefGoogle Scholar
  77. Ribeiro, S. A., and Rocha e Silva, M., 1973, Antinociceptive action of bradykinin and related kinins of larger molecular weight by the intraventricular route, Br. J. Pharmacol. 47:517–528.PubMedGoogle Scholar
  78. Ribeiro, S. A., DaSilva, G. R., Camargo, A. C. M., and Corrado, A. P., 1970, Hyperglycemia induced in the rabbit by intraventricular injection of bradykinin, Adv. Exp. Med. Biol. 8:635–639.Google Scholar
  79. Ribeiro, S. A., Corrado, A. P., and Rocha e Silva, M., 1971, Antinociceptive action of intraventricular bradykinin, Neuropharmacology 10:725–731.PubMedCrossRefGoogle Scholar
  80. Rocha e Silva, M., Beraldo, W. T., and Rosenfeld, G., 1949, Bradykinin, a hypotensive and smooth muscle stimulating factor released from plasma globulin by snake venoms and by trypsin, Am. J. Physiol. 156:261–273.PubMedGoogle Scholar
  81. Roscher, A. A., Manganiello, V. C., Jelsema, C. L., and Moss, J., 1984, Autoregulation of bradykinin receptors and bradykinin-induced prostacyclin formulation in human fibroblasts, J. Clin. Invest. 74:552–558.PubMedCrossRefGoogle Scholar
  82. Shikimi, T., Kema, R., Matsumoto, M., Yamahata, Y., and Miyata, S., 1973, Studies on kinin-like substances in brain, Biochem. Pharmacol. 22:567–573.PubMedCrossRefGoogle Scholar
  83. Simson, J. A. V., Dom, R., Chao, J., Chao, L., and Margolius, H. S., 1985, Immunocytochemical localization of tissue kallikrein in brain ventricular epithelium and hypothalamic cell bodies, J. Histochem. Cytochem. 33:951–953.PubMedCrossRefGoogle Scholar
  84. Snider, R. M., and Richelson, E., 1984, Bradykinin receptor-mediated cyclic GMP formation in a nerve cell population (murine neuroblastoma clone NIE-115), J. Neurochem. 43:1749–1754.PubMedCrossRefGoogle Scholar
  85. Stewart, J. M., and Vavreck, R. J., 1985, Competitive antagonists of bradykinin, Peptides 6:161–164.PubMedGoogle Scholar
  86. Stoner, J., Manganiello, V. C., and Vaughan, M., 1973, Effects of bradykinin and indomethacin on cyclic GMP and cyclic AMP in lung slices, Proc. Natl. Acad. Sci. U.S.A. 70:3830–3833.PubMedCrossRefGoogle Scholar
  87. Takahashi, H., and Bunag, R. D., 1981, Centrally induced cardiovascular and sympathetic nerve responses to bradykinin in rats, J. Pharmacol. Exp. Ther. 216:192–197.PubMedGoogle Scholar
  88. Thomas, G. R., Thibodeaux, H., Margolius, H. S., and Privitera, P. J., 1984, Cerebrospinal fluid kinins and cardiovascular function, Hypertension 6(Suppl. I): 146–150.Google Scholar
  89. Tomita, K., and Pisano, J. J., 1984, Binding of [3H]bradykinin in isolated nephron segments of the rabbit, Am. J. Physiol. 246:F732–F737.PubMedGoogle Scholar
  90. Ueda, N., Muramatsu, I., and Fujiwara, M., 1984, Capsaicin and bradykinin-induced substance P-ergic responses in the iris sphincter muscle of the rabbit, J. Pharmacol. Exp. Ther. 230:469–473.PubMedGoogle Scholar
  91. Unger, T., Rockhold, R. W., Kaufman-Buhler, I., Hubner, D., Schull, B., and Ganten, D., 1980, Effects of angiotensin concerting enzyme inhibitors on the brain, in: Angiotensin Converting Enzyme Inhibitors (Z. P. Horovitz, ed.), Urban & Schwarzenberg, Baltimore, pp. 55–79.Google Scholar
  92. Wahlestedt, C., Bynke, G., and Hakanson, R., 1985, Pupillary constriction by bradykinin and capsaicin: Mode of action, Eur. J. Pharmacol. 106:577–583.CrossRefGoogle Scholar
  93. Werle, V. E., and Zack, P., 1970, Verteilung von Kininogen in Serum und Geweben bei Ratten und anderen Sangetieren, Z. Klin. Chem. Klin. Biochem. 8:186–189.PubMedGoogle Scholar
  94. Wilk, S., and Orlowski, M., 1979, Degradation of bradykinin by isolated neutral endopeptidases of brain and pituitary, Biochem. Biophys. Res. Commun. 90:1–6.PubMedCrossRefGoogle Scholar
  95. Yang, H. Y. T., and Neff, N. H., 1972, Distribution and properties of angiotensin converting enzyme of rat brain, J. Neurochem. 19:2443–2450.PubMedCrossRefGoogle Scholar
  96. Yano, K., Higashida, H., Inoue, R., and Nozawa, Y., 1984, Bradykinin-induced rapid breakdown of phosphatidylinositol 4,5-bisphosphate in neuroblastoma × glioma hybrid NG108-15 cells, J. Biol. Chem. 259:10201–10207.PubMedGoogle Scholar
  97. Yano, K., Higashida, H., Hattori, H., and Nozawa, Y., 1985, Bradykinin-induced transient accumulation of inositol trisphosphate in neuron-like cell line NG108-15 cell, EEBS Lett. 181:403–406.Google Scholar
  98. Yasujima, M., Matthews, P. G., and Johnston, C. I., 1981, Regulation of uterine smooth muscle bradykinin receptors by bradykinin and angiotensin converting enzyme inhibitor in the rat, Clin. Exp. Pharmacol. Physiol. 8:515–518.PubMedCrossRefGoogle Scholar
  99. Zenser, T. V., Rapp, N. S., Spry, L. A., and Davis, B. B., 1984, Independent effects of bradykinin on adenosine 3′,5′-monophosphate and prostaglandin E2 metabolism by rabbit renal medulla, Endocrinology 114:541–544.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1986

Authors and Affiliations

  • David C. Perry
    • 1
  1. 1.Department of PharmacologyGeorge Washington University Medical CenterUSA

Personalised recommendations